Summary and conclusions Patterns of recurrent disease were analysed in 603 patients with breast cancer. The time of onset, frequency of recurrence, and survival after recurrence were not influenced by age or menopausal state. While survival after local recurrence was longer than survival after distant metastasis, the time to onset of local and distant disease followed an identical pattern, indicating that local recurrence should be regarded as a manifestation of systemic disease. Postoperative radiotherapy did not affect the time of onset of local recurrence.
more, the quality of the blood samples obtained by placentocentesis is inferior, and repeated attempts are more often necessary.
The red-cell values available at present4 are based on old data; while ours (table II) are broadly similar, confirming that fetuses at this stage of pregnancy have a low red-cell count and packed cell volume and a high mean red-cell volume compared with adults, there are enough differences to suggest that further basic haematological information must be collected from fetoscopic samples. If pure fetal blood is consistently obtainable many physiological and pathological processes could be studied. We are currently investigating creatine phosphokinase 7 and factor VIII concentrations in fetal blood.
Introduction
The survival of patients with cancer of the breast has not improved greatly in recent years.1-3 Many carefully controlled trials of different methods of treatment have been carried out,4-7 yet the results have shown remarkably little variation in the interval before metastases appear, or in survival, whatever the primary treatment. While a great deal of information is available on the management of so-called early breast cancer, little is known about the prognostic importance of different patterns of recurrent disease. Some patients with "local" recurrence have no evidence of distant metastases clinically or on investigation, yet many clinicians believe that local recurrence is a manifestation of systemic disease.8-10 It is not clear, however, whether systemic treatment should be used in patients with locally recurrent disease.
There have been suggestions that postoperative radiotherapy may enhance dissemination of the tumour, but there is little information on the influence of radiotherapy on survival after metastases. The effect of menopausal state on the prognosis of recurrent disease is also poorly documented, as is the relation between the site of the primary tumour in the breast and the time of appearance of metastases. We therefore analysed in detail many patients with breast cancer treated in this hospital and tried to find out whether local and distant recurrences occur at similar times after primary treatment; postoperative radiotherapy delays the onset of local recurrence or influences survival once metastases have occurred; survival is different after local or distant metastasis; and menopausal state and age influence the time of onset of recurrence and survival after recurrence.
Patients and methods During 1968-76, 603 patients with histologically proved adenocarcinoma of the breast were treated in this hospital; of these, 503 underwent simple mastectomy, 34 radical mastectomy, and 56 excision of the lump followed by radiotherapy. At the time there was a change from treatment by radical mastectomy in favour of local mastectomy followed by radiotherapy because it had been clearly shown that whereas there was little difference in survival with these two procedures, the morbidity associated with local mastectomy was less. Treatment policy was not standard, however, and some patients were selected for local excision because of variable criteria such as age or refusal to undergo mastectomy. Nevertheless, a general policy emerged, and most patients with medial tumours received radiotherapy, but many of those with lateral tumours and unaffected axillary nodes did not. Radiotherapy to the regional lymph nodes was given to all patients after operation if the axillary nodes were shown to be affected by cancer or if the tumour affected the medial half of the breast. The axilla and supraclavicular nodes received a total dose of 4500 rads over six weeks. In addition radiation to the chest wall after mastectomy or to the residual breast after excision of the lump was carried out in over 90% of patients who underwent postoperative irradiation, the total dose being 3000-3500 rads over six weeks. Influence of tumour site on onset of recurrence-The time to recurrent disease was not influenced by the site of the primary tumour in the breast. Laterally placed tumours were those that were macroscopically confined to the lateral half of the breast, while a tumour was deemed to be medially placed if it encroached on the medial half of the breast. Proportions of patients free of recurrence at three and five years were 54% and 45% respectively in patients with lateral tumours and 46% and 36% respectively in those with medial tumours.
Survival after local and distant recurrence-Survival in patients with locally recurrent disease as the first and only manifestation ofmetastasis was significantly longer than in those in whom distant metastasis was the first indication of recurrence (fig 4) . At three years after recurrence 61 (40 5%) of those with local recurrence were alive, while only 33 patients (15-5%) with distant metastasis were alive (P<00001).
The figures for five years were 39 (26%) and 9 (4%) respectively. Thus, although local recurrence as the first manifestation of spread of the disease appears at the same time as distant metastasis, its prognosis, though very poor, is better than that of distant recurrence. patients whose first recurrence was local or regional (dashed line) and 215 patients in whom distant metastasis was first sign of recurrence (black line).
Influence of postoperative radiotherapy on survival after recurrenceIn patients who had received postoperative radiotherapy as treatment of the primary disease there was no difference in survival once recurrence had appeared. Survival rates at three and five years after recurrence were 25% and 12-5% respectively in the irradiated group and 31% and 17 5% respectively in those who had not received radiotherapy.
Influence of age and menopausal state on survival after recurrenceIn patients who developed recurrence survival was not influenced by age or menopausal state at the time of initial presentation. Three-year survival figures were 29-5% in those aged under 40, 35-5% in the 40-49 group, 23% in the 50-59 group, and 23% in those aged over 60. Five-year survival was in the range 13-17% for all groups. Of the 70 premenopausal women who developed recurrence, 23 (33°04) were alive three years later, as were 66 (24%) of the 274 postmenopausal women (P=0-16).
Discussion
Our findings showed that the time from first treatment of breast cancer to the development of distant metastases was identical with the disease-free interval before local recurrence. This result strongly suggests that the same systemic mechanisms govern the appearance of both local and distant metastases. The exponential curve that describes the onset of recurrence in both instances shows a constant risk of recurrence throughout the period of observation. Locally recurrent cancer of the breast may be regarded as an outward manifestation of disseminated disease, and systemic treatment should be considered in addition to irradiation of the chest wall. Survival data, however, show a clear advantage in favour of the local recurrence group, even though the prognosis is poor in both.
Longer survival after local recurrence has long been recognised but not fully explained. Possibly local recurrence is usually detected when the tumour mass is relatively small, indicating an earlier stage in the natural history of the disease in the patient and making the condition more amenable to treatment. Furthermore, local recurrence, in contrast to distant metastases, is unlikely to cause death, and when identified, systemic treatment is often begun. It might be argued that because primary surgical treatment was not standardised in our series conclusions about the incidence of local and disseminated disease are not justified. Nevertheless, the recurrence rate and pattern in each of the three surgical groups (simple mastectomy, radical mastectomy, and excision of the tumour) were not significantly different.
Postoperative irradiation did not affect the time of onset of local recurrence. The patients who received irradiation were not a homogeneous population because some had undergone radiotherapy and excision of the lump, others had received irradiation because of axillary node disease, and others were irradiated because they had a medial tumour. Radiotherapy may prevent local recurrence,12-'4 but local recurrence appears at the same time in patients who have received radiotherapy and those who have not, and seems to have the same general importance.
We found no evidence to suggest that metastasis tends to occur earlier at any particular site, which supports the notion that a systemic change in patients allows micrometastases to grow and governs the clinical presentation. We did not find that age or menopausal state influenced the onzet of metastases, though these factors have been shown to play a part in the development of cancer of the breast. ' Recently the use of adjuvant chemotherapy after surgery for breast cancer has aroused considerable interest, and some encouraging early results have been obtained, particularly in premenopausal women, using both single agents and combined chemotherapy.'9 20 Trials of adjuvant chemotherapy are timeconsuming, since several years must pass before an impact on survival can be observed. Moreover, even patients with affected axillary nodes are sometimes treated needlessly. The drug schedules which are used in trials of adjuvant chemotherapy have been derived from studies in advanced breast cancer. The susceptibility of breast cancer to the effects of cytotoxic drugs may be quite different, however, when the tumour mass is small. Locally recurrent breast cancer provides an ideal setting for studying the effect of cytotoxic agents for the following reasons: almost all the patients have a poor prognosis; the results will be apparent within two or three years; the patients have a small tumour mass, so conditions resemble those in which adjuvant chemotherapy is used; and there are at present a few long-term survivors, which implies that an effective treatment will be detected readily. Local recurrence is a form of recurrent disease that allows direct, measurable evidence of the effects of treatment. Locally recurrent breast cancer may well be the best model from which to find the most effective and least toxic adjuvant drug combination in clinical trials.
Summary and conclusions
Although ventricular tachycardia is a well-known complication of myocardial ischaemia and may be provoked by exercise, many patients may appreciate only the angina and be unaware of the unduly rapid heart rate that precipitates it. Exercise testing is needed to show this arrhythmia and to enable treatment to be started.
Twenty-three patients were found to have chronic ischaemic heart disease complicated by ventricular tachycardia. Six patients with old myocardial infarction had ventricular tachycardia at rest which required conversion to sinus rhythm; 17 patients developed ventricular tachycardia only when they exercised. In 12 of these 17 patients coronary angiography showed disease of the anterior descending branch of the left coronary artery; other vessels were usually also affected. Although beta-adrenergic blocking drugs increased exercise tolerance, ventricular tachycardia still occurred when the heart rate on exercise reached a level similar to that before treatment. In five patients coronary artery bypass surgery was performed because of angina and exercise-induced ventricular tachycardia. Exercise tolerance was increased in all three patients who underwent exercise tests after operation, and in two of these patients, both of whom were known to have patent grafts, ventricular tachycardia was abolished. conventionally on paper and on electromagnetic tape, and the heart rate and rhythm were monitored and S-T segment displacement observed. Ventricular tachycardia was diagnosed when three or more ventricular extrasystoles in a row (separated on average by < 600 ms) occurred. Whenever possible patients who developed ventricular tachycardia on or after exercise were exercised again while on treatment.
Coronary arteriography and left ventricular angiography were performed by the femoral percutaneous technique.6 All patients were followed up for at least three months after the last therapeutic intervention.
Results
Altogether 870 patients performed treadmill exercise tests, and ventricular arrhythmias were recorded in 144 during or after exercise. Ventricular tachycardia was found in 33 of these patients, 17 of whom had ischaemic heart disease. Of these 17, 12 had lesions on coronary arteriography; two had electrocardiographic evidence of anterior myocardial infarction as well as significant S-T segment depression (>0 2 mV) with angina after exercise; and three had S-T changes during and after exercise that suggested ischaemia. Ventricular tachycardia had been suspected in only two patients before exercise testing.
